Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Year-over-year debt growth rate
5Y CAGR
-62.5%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 2.89% |
| Q2 2025 | 11.03% |
| Q1 2025 | 6.35% |
| Q4 2024 | -4.14% |
| Q3 2024 | 7.43% |
| Q2 2024 | 2.06% |
| Q1 2024 | 2.01% |
| Q4 2023 | 22545.90% |
| Q3 2023 | -58.50% |
| Q2 2023 | -45.35% |
| Q1 2023 | -40.62% |
| Q4 2022 | 7.86% |
| Q3 2022 | -19.85% |
| Q2 2022 | 54.57% |
| Q1 2022 | -70.80% |
| Q4 2021 | -13.81% |
| Q3 2021 | 74.26% |
| Q2 2021 | 110.05% |
| Q1 2021 | -17.49% |
| Q4 2020 | 82.79% |
| Q3 2020 | 388.00% |
| Q2 2020 | -12.28% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | -100.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |